Pharma Foods International Co., Ltd.【JP:2929】Balance sheet
Market cap
¥20.1B
P/E ratio
19.9x
| 2013/07 | 2014/07 | 2015/07 | 2016/07 | 2017/07 | 2018/07 | 2019/07 | 2020/07 | 2021/07 | 2022/07 | 2023/07 | 2024/07 | 2025/07 | |
| Cash and cash equivalents | - | 1,514 | 1,509 | 2,101 | 2,861 | 2,934 | 4,317 | 3,283 | 9,794 | 8,845 | 16,306 | 15,666 | 9,157 |
| Total cash & short-term investments | - | 1,514 | 1,509 | 2,101 | 2,861 | 2,934 | 4,317 | 3,283 | 9,794 | 8,845 | 16,306 | 15,666 | 9,157 |
| Accounts receivable, net | - | - | - | 592 | 593 | 880 | 1,281 | 2,239 | 4,920 | 6,702 | 4,058 | 4,038 | 5,038 |
| Inventories | - | 194 | 215 | 212 | 565 | 596 | 988 | 1,582 | 2,659 | 4,704 | 4,594 | 5,292 | 6,311 |
| Total current assets | - | 2,536 | 2,455 | 3,160 | 4,367 | 4,730 | 6,888 | 7,437 | 17,933 | 23,513 | 27,530 | 27,275 | 23,870 |
| Property, plant and equipment, net | - | 705 | 717 | 725 | 718 | 734 | 955 | 1,769 | 1,808 | 4,458 | 4,404 | 4,609 | 4,696 |
| Marketable securities, non-current | - | 347 | 147 | 102 | 40 | 139 | 146 | 137 | 335 | 1,572 | 2,514 | 3,037 | 2,450 |
| Total non-current assets | - | 1,398 | 1,284 | 1,313 | 1,477 | 1,601 | 1,843 | 2,659 | 3,010 | 7,645 | 8,701 | 9,298 | 8,778 |
| Total assets | - | 3,934 | 3,739 | 4,473 | 5,844 | 6,330 | 8,731 | 10,096 | 20,944 | 31,159 | 36,232 | 36,573 | 32,649 |
| Accounts payable | - | - | - | 89 | 139 | 199 | 267 | 450 | 846 | 1,176 | 937 | 1,250 | 1,923 |
| Short-term debt | - | - | - | 50 | 50 | 50 | - | - | 2,500 | 15,400 | 17,400 | 14,900 | 11,400 |
| Long-term debt, current | - | - | - | 199 | 447 | 443 | 1,062 | 1,276 | 939 | 760 | 955 | 760 | 560 |
| Total current liabilities | - | 209 | 266 | 515 | 1,086 | 1,426 | 2,338 | 2,838 | 10,978 | 22,795 | 24,374 | 23,163 | 20,005 |
| Long-term debt, non-current | - | - | - | 429 | 1,088 | 920 | 2,045 | 2,302 | 1,458 | 697 | 1,741 | 1,231 | 671 |
| Total non-current liabilities | - | 34 | 20 | 461 | 1,166 | 994 | 2,078 | 2,351 | 1,499 | 1,288 | 2,227 | 1,824 | 1,096 |
| Total liabilities | - | 243 | 286 | 976 | 2,251 | 2,420 | 4,415 | 5,189 | 12,478 | 24,084 | 26,601 | 24,987 | 21,101 |
| Common stock and paid-in capital | - | 3,891 | 3,913 | 3,913 | 3,913 | 3,914 | 3,843 | 3,845 | 3,855 | 3,862 | 3,857 | 3,857 | 3,857 |
| Retained earnings | - | -323 | -511 | -455 | -354 | -40 | 459 | 1,049 | 4,599 | 3,300 | 5,792 | 8,356 | 7,691 |
| Stockholders' equity | 2,666 | 3,691 | 3,453 | 3,497 | 3,592 | 3,910 | 4,316 | 4,907 | 8,465 | 7,074 | 9,630 | 11,585 | 11,547 |
| Total debt | - | - | - | 679 | 1,584 | 1,413 | 3,107 | 3,578 | 4,897 | 16,857 | 20,096 | 16,891 | 12,631 |
| Net debt | - | - | - | -1,422 | -1,277 | -1,522 | -1,209 | 295 | -4,897 | 8,012 | 3,790 | 1,225 | 3,474 |
| D/E ratio (%) | - | - | - | 19.4 | 44.1 | 36.1 | 72 | 72.9 | 57.8 | 238.3 | 208.7 | 145.8 | 109.4 |
| Working capital | - | - | - |